Brandes, A. H., Ward, C. S., & Ronen, S. M. (2010). 17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2. BioMed Central.
Chicago-tyylinen lähdeviittausBrandes, Alissa H., Christopher S. Ward, ja Sabrina M. Ronen. 17-allyamino-17-demethoxygeldanamycin Treatment Results in a Magnetic Resonance Spectroscopy-detectable Elevation in Choline-containing Metabolites Associated With Increased Expression of Choline Transporter SLC44A1 and Phospholipase A2. BioMed Central, 2010.
MLA-viiteBrandes, Alissa H., Christopher S. Ward, ja Sabrina M. Ronen. 17-allyamino-17-demethoxygeldanamycin Treatment Results in a Magnetic Resonance Spectroscopy-detectable Elevation in Choline-containing Metabolites Associated With Increased Expression of Choline Transporter SLC44A1 and Phospholipase A2. BioMed Central, 2010.